Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Current Pharmaceutical Biotechnology|August 22, 2023
Drug Repositioning Using Computer-aided Drug Design (CADD)Sona Rawat, Kanmani Subramaniam, Selva Kumar Subramanian, et al.The Journal of Physical Chemistry. A|December 12, 2022
Balancing Panchromatic Absorption and Multistep Charge Separation in a Compact Molecular ArchitectureArpita Roy, Nikki Cecil M Magdaong, Haoyu Jing, et al.Oncotarget|November 4, 2021
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survivalSara Maimouni, Mi-Hye Lee, You-Me Sung, et al.Oncotarget|March 23, 2019
Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survivalSara Maimouni, Mi-Hye Lee, You-Me Sung, et al.The Astronomical Journal|March 20, 2024
Broadband Stability of the Habitable Zone Planet Finder Fabry-Pérot Etalon Calibration System: Evidence for Chromatic VariationRyan C Terrien, Joe P Ninan, Scott A Diddams, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|July 28, 2022
Hematological Abnormalities and Comorbidities Are Associated With the Severity of Kidney Disease: A Hospital-Based Cross-Sectional Study in BangladeshMd Ashrafur Rahman, Yeasna Shanjana, Md Shakil Ahmed, et al.Frontiers in Pharmacology|August 19, 2022
Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological TargetsMumtaza Mumu, Ayan Das, Talha Bin Emran, et al.Molecules (Basel, Switzerland)|September 23, 2022
Phenolic Constituents from Wendlandia tinctoria var. grandis (Roxb.) DC. Stem Deciphering Pharmacological Potentials against Oxidation, Hyperglycemia, and Diarrhea: Phyto-Pharmacological and Computational ApproachesMamtaz Farzana, Md Jamal Hossain, Ahmed M El-Shehawi, et al.Plos One|July 22, 2021
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladderYoung H Lee, Molly M Lee, Dinuka M De Silva, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast CancerMelanie Royce, Christy Osgood, Flora Mulkey, et al.Pageof 19